7struthers A D,AL dosterone escape during ACE inhibitor therapy in chronic heart failure. Eur Heart J,1995,16:103 ～106.
8Carson P E. Rational for the use of combination angiotensin - converting enayme inhibitor/angiotensin Ⅱ receptor blocker therapy in heart failure.Am Heart,2000,140:361 ～366.
9[1]The CONSENSUS Trial Stuty Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian enalapril survival study (CONSENSUS).New Engl J Med,1987,316(23):1429-1435.
10[2]Struthers AD.Aldosterone escape during ACE-inhibitor therapy in chronic heart failure. Eur heart J,1995,16(Suppl N):103-106.
1Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international and Federation of cardiology world Health Organ- ization task force on Standarization of clinical nomendature. Circulation, 1979,59:607-609.
3Pitt B, Zannad F, Remme WJ, et al. Augmented short and long term he- modynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. N Eng J Med,1999,341:709-717.
4Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensin converting en- zyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin 1I type 2 receptors. J Clin In- vest, 1997,99 : 1926-1935.
5Richer C ,Fomes P,Cazaubon C ,et al. Effects of longterm angiotensin 11 AT1 receptor blockade on survival,hemodynamics and cardiac remodeling in chronic heart failure in rats J. Cardiovasc Res,1999,41:100-108.
6Cohn JN, Tognoni G. A randomized trial of the angiotensin receptorblock- er valsartan in chronic heart failure. N Eng J Med,2001,345:1667- 1675.
